These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748 [No Abstract] [Full Text] [Related]
6. Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway. Lei R; Zhang S; Wang Y; Dai S; Sun J; Zhu C Int J Med Sci; 2019; 16(7):960-966. PubMed ID: 31341409 [No Abstract] [Full Text] [Related]
7. PKM2 and HIF-1α regulation in prostate cancer cell lines. Hasan D; Gamen E; Abu Tarboush N; Ismail Y; Pak O; Azab B PLoS One; 2018; 13(9):e0203745. PubMed ID: 30216369 [TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421 [TBL] [Abstract][Full Text] [Related]
10. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. Dai J; Escara-Wilke J; Keller JM; Jung Y; Taichman RS; Pienta KJ; Keller ET J Exp Med; 2019 Dec; 216(12):2883-2899. PubMed ID: 31548301 [TBL] [Abstract][Full Text] [Related]
11. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells]. Konno M; Hamabe A; Doki Y; Mori M; Ishii H Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567 [TBL] [Abstract][Full Text] [Related]
12. KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC. Wang HJ; Pochampalli M; Wang LY; Zou JX; Li PS; Hsu SC; Wang BJ; Huang SH; Yang P; Yang JC; Chu CY; Hsieh CL; Sung SY; Li CF; Tepper CG; Ann DK; Gao AC; Evans CP; Izumiya Y; Chuu CP; Wang WC; Chen HW; Kung HJ Oncogene; 2019 Jan; 38(1):17-32. PubMed ID: 30072740 [TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells. de Wit RH; Mujić-Delić A; van Senten JR; Fraile-Ramos A; Siderius M; Smit MJ Oncotarget; 2016 Oct; 7(42):67966-67985. PubMed ID: 27602585 [TBL] [Abstract][Full Text] [Related]
15. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells. Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080 [TBL] [Abstract][Full Text] [Related]
16. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress. Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265 [TBL] [Abstract][Full Text] [Related]
18. Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells. Tao T; Li G; Dong Q; Liu D; Liu C; Han D; Huang Y; Chen S; Xu B; Chen M Tumour Biol; 2014 Sep; 35(9):8543-50. PubMed ID: 24859886 [TBL] [Abstract][Full Text] [Related]
19. Changes in PKM2 associate with prostate cancer progression. Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829 [TBL] [Abstract][Full Text] [Related]
20. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]